These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


321 related items for PubMed ID: 23908122

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Applications of diffusion-weighted magnetic resonance imaging in renal cell carcinoma.
    Wang H, Zhang X, Ye H.
    Expert Rev Anticancer Ther; 2011 Jul; 11(7):1017-22. PubMed ID: 21806325
    [Abstract] [Full Text] [Related]

  • 24. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
    Chen J, Qian T, Zhang H, Wei C, Meng F, Yin H.
    Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI.
    Tan SL, Rahmat K, Rozalli FI, Mohd-Shah MN, Aziz YF, Yip CH, Vijayananthan A, Ng KH.
    Clin Radiol; 2014 Jan; 69(1):63-71. PubMed ID: 24156797
    [Abstract] [Full Text] [Related]

  • 27. Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging.
    Park JJ, Kim CK, Park SY, Simonetti AW, Kim E, Park BK, Huh SJ.
    Magn Reson Imaging; 2014 Oct; 32(8):993-1000. PubMed ID: 24970025
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Noncompartmental kinetic analysis of DCE-MRI data from malignant tumors: Application to glioblastoma treated with bevacizumab.
    Port RE, Bernstein LJ, Barboriak DP, Xu L, Roberts TP, van Bruggen N.
    Magn Reson Med; 2010 Aug; 64(2):408-17. PubMed ID: 20665785
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
    Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JF.
    J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
    [Abstract] [Full Text] [Related]

  • 32. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab.
    Hsu YH, Ferl GZ, Ng CM.
    Magn Reson Imaging; 2013 May; 31(4):618-23. PubMed ID: 23200680
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Advantages of high b-value diffusion-weighted imaging to diagnose pseudo-responses in patients with recurrent glioma after bevacizumab treatment.
    Yamasaki F, Kurisu K, Aoki T, Yamanaka M, Kajiwara Y, Watanabe Y, Takayasu T, Akiyama Y, Sugiyama K.
    Eur J Radiol; 2012 Oct; 81(10):2805-10. PubMed ID: 22100373
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Connective tissue of cervical carcinoma xenografts: associations with tumor hypoxia and interstitial fluid pressure and its assessment by DCE-MRI and DW-MRI.
    Hompland T, Ellingsen C, Galappathi K, Rofstad EK.
    Acta Oncol; 2014 Jan; 53(1):6-15. PubMed ID: 23445339
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.